Main content 1 Menu 2 Search 3 Footer 4
+A
A
-A
High contrast
HOME JOURNAL CRITERIA NETWORK HELP ABOUT

Current criteria:

Regional:

WPRlM journal selection criteria(2023)

Minimum standards for the suspension and removal of WPRIM approved journals

Countries journal selection criteria:

Philippines

Submit your journal information>

Contact NJSCs>

Journal of Clinical Medicine in Practice

2002 (v1, n1) to Present ISSN: 1671-8925

Articles

About

Year of publication

Save Email

Sort by

Best match
Relevance
PubYear
JournalTitle

DISPLAY OPTIONS

Format:

Per page:

Save citations to file

Selection:

Format:

Create file Cancel

Email citations

To:

Please check your email address first!

Selection:

Format:

Send email Cancel

4889

results

page

of 489

1

Cite

Cite

Copy

Share

Share

Copy

New developments in primed in situ labeling (PRINS) methods and applications

Journal of Clinical Medicine in Practice.2002;6(3):169-174. doi:10.3969/j.issn.1672-2353.2002.03.001

To present a brief review on primed in situ labeling (PRINS) methods and applications.PRINS is a new molecular cytogenetic method and could serve as an alternative to, as well as a complementary approach to fluorescence in situ hybridization (FISH) for chromosome studies.PRINS can provide fast (1-4 h),reliable,and cost-effective results.Development of multi-color PRINS makes it possible to study several chromosome targets simultaneously.PRINS can detect repetitive(e.g.centromeric,telomeric or Alu repeats) and single copy sequences/genes,depending on the primers used.It is applicable to metaphase and interphase cells in postnatal,prenatal,or preimplantation diagnosis.PRINS has great potential in chromosome research and diagnosis,including:①identification of numerical aberrations(e.g.trisomies 21,13,and 18 and 45,X),②detection of chromosome markers,③rapid screening for subtelomere deletions,④diagnosis of microdeletion syndromes(e.g. Prader Willi/Angelman and DiGeorge/Velocardiofacial syndromes),⑤Chromosome studies in sperm,⑥preimplantation screening of common aneuploidies,and ⑦cancer cytogenetics.

2

Cite

Cite

Copy

Share

Share

Copy

STUDIES OF ANALGESIC PROPERTIES OF ETHANOLIC EXTRACT FROM POTENTILLA FRENIANA BORNM.VAR.SINICA MIGO

Journal of Clinical Medicine in Practice.2002;6(3):200-203. doi:10.3969/j.issn.1672-2353.2002.03.012

Objective:To evaluate the analgesic effect from the ethanolic extract of Potentilla freyniana Bornm. var. Sinica Migo (PBSM).Methods:The analgesic properties of PBSM were investigated by the classical hot plate test and the writhing test.Results:In the hot plate test,the ethanolic extract of PBSM(0.5g/kg,1.25 g/kg,2.5g/kg,o.p.) significantly delayed the response time to hot-plate thermal stimulation 15,30,60 and 90 min after treatment,and 90 min after treatment,the effect of PBSM (2.5g/kg) was higher than that of aminopyrine (100 mg/kg i.m.).In the writhing test, which is more sensitive for non-steroidal analgesics, the ethanolic extract of PBSM (0.5g/kg,1.25g/kg,2.5g/kg o.p.) dose significantly inhibited the writhes induced by 0.7% acetic acid.Conclusion:Potentilla freyniana Bornm.var.Sinica Migo may have analgesic activity and affirm the claim by traditional medicine practitioners of the use in toothache or some painful conditions.

3

Cite

Cite

Copy

Share

Share

Copy

MICROARRAYS AND THEIR POTENTIAL IN MEDICINE

Ling ERICK ; Xu JIE

Journal of Clinical Medicine in Practice.2003;7(1):66-70.

Advancement in microarray technology can revolutionize many aspects of medicine. Microarrays have applications in gene expression profiling, genotyping, mutation analysis, gene identification, and pharmacology. This paper provides a brief review on the use of microarrays in studies of cancer, infectious diseases, chromosome disorders, neurological/mental disorders, and drugs, along with a prospect on its great potential in diagnosis, prognosis and the treatment of human diseases.

4

Cite

Cite

Copy

Share

Share

Copy

LAPAROSCOPIC TREATMENT OF ACUTE CHOLECYSTITIS

Nyamkhuu DAVAADORJ ; Gonchigsenghe NYAMKHUU ; Rusher Holly ALBERT

Journal of Clinical Medicine in Practice.2003;7(5):397-399.

Objctive: To assess the current treatment of AC in a single institution in the series,which the best treatment modality for acute cholecystitis (AC) is still under debate, whereas early cholecystectomy is accepted as the optimal timing for surgery. Methods: From December 1996 to December 2001,138 (102 women and 36 men) patients underwent laparoscopic cholecystectomy for acute cholecystitis confirmed by histopathological examination. The patients ranged in age from 21 to 85 years of age ( mean age:45.3 years). Patients were divided into 2 groups (similar in age and ASA classification): group 1 (98 patients) underwent LC within 3 days after the onset of symptoms of acute cholecystitis and group 2 (40 patients) underwent LC after 3 days. Results: Approximately one half of the cases were uncomplicated, 26 % were empyema, 13 % had gangrenous changes and 7% had hydrops of the gallbladder. Conversion to open cholecystectomy was required in 21 (15.2%) cases. The principal reason for conversion was anatomic uncertainty (14 cases), uncontrolled bleeding (7 cases). The conversion rates in patients who underwent surgery before and after the onset of symptoms were respectively 6:15. There was no significant difference in operative time (122.0 min in 1 group versus 124.0 min in 2 group) and postoperative stay ( 5.1 days in group 1 vs 6.8 days in group 2). The hepatorenal space was drained in 78 (56.5 % ), and the drain is removed in 3rd postoperative days. Twenty six patients (18.8%) had undergone previous abdominal surgery. Thirty seven patients (26.8%) had spillage of bile and/or stones during the procedure. There were no deaths and major complications. Conclusions: LC for acute cholecystitis should be done immediately after the diagnosis is established because delaying surgery allows inflammation to become more intense,thus increasing the technical difficulty of LC. Intraoperative spillage of bile and stones does not lead to an increase in early complications. LC is safe and effective for acute cholecystitis even when complicated previous surgery, inflammatory adhesions and gangrene. LC has significantly fewer operative complications and provides shorter hospital stay which are medical and economic benefits. LC is safe and effective for acute cholecystitis.

5

Cite

Cite

Copy

Share

Share

Copy

LEAKAGE OF COLONIC ANASTOMOSIS AFTER COLON RESECTION

I KANELLOS ; MG PRAMATEFTAKIS

Journal of Clinical Medicine in Practice.2004;8(6):1-4.

Objective To present the diagnosis and management of anastomotic leakage after colon resection. Methods Early diagnosis and urgent therapeutic intervention are required in order to avert life-threatening conditions that may be caused by anastomotic leakage. Results The diagnosis of anastomotic leakage is based on clinical features, peripheral blood investigations and abdominal computed tomography (CT) scan. Major leaks are defined by symptoms of peritonitis and septicaemia due to leakage. Major leaks should be managed operatively. Minor leaks can be managed conservatively with successful outcomes. Conclusion Leakage of colonic anastomosis remains the most serious complication after colon resection. It is a major cause of postoperative morbidity and mortality. A high index of suspicion is required in order to detect early, nonspecific signs of a leakage and urgent surgical intervention is usually required to avert life-threatening events.

6

Cite

Cite

Copy

Share

Share

Copy

INCREMENTAL DYNAMIC COMPUTER TOMOGRAPHY IN SURGICAL TREATMENT OF PATIENTS WITH SOLITARY PULMONARY NODULES

Ya-Bing ZHU ; Cheng-Feng CHU ; Zhi-Yong LIU ; Dan-Ning YANG ; Qiu-Zhen XU ; Ming YANG

Journal of Clinical Medicine in Practice.2006;10(7):19-22,27.

Objective The purpose of this study is to appraise the value of incremental dynamic enhanced computed tomography in surgical treatment of patients with solitary pulmonary nodules (SPNs). Methods The data of 42 cases with solitary pulmonary nodules who underwent surgical treatment from May 2002 to June 2003 in our hospital were collected to find the relationship between preoperative dynamic enhanced CT image and postoperative pathology. Result All bronchogenic carcinoma showed significant enhancement after intravenous 100 mL iodinated contrast material. The average degree of enhancement of bronchogenic carcinoma was significantly different from that of tuberculoma and other benign lesions. Conclusion Dynamic enhanced computed tomography is very valuable in distinguishing between malignant nodules and benign ones. Emphasis should be paid to lymph nodes in the dynamic enhanced computed tomography, which is useful both to the diagnosis of SPN and for surgical treatment.

7

Cite

Cite

Copy

Share

Share

Copy

Effect of Endostar Combined with Gemcitabine on the Mouse Model of Human Pancreatic Cancer

Qing-Feng LIN ; Rong-Sheng WANG ; Ren-Hua GUO ; Yong-Biao LIU ; Yong-Qian SHU

Journal of Clinical Medicine in Practice.2007;11(3):19-23. doi:10.3969/j.issn.1672-2353.2007.03.006

Objective To investigate the effects of recombinant human endostatin,that is,endostar combined with gemcitabine on the mouse model of human pancreatic cancer.Methods We use the cell line PANC-1 and the severe combined immune deficient mice to set up the mouse model of human pancreatic cancer,then devide them into three groups,treat them with gemcitabine,gemcitabine combined with endostar,and 0.9% saline water respectively.We observe the change of the tumor volumn,use ELISA method to detect the serum VEGF level,stain the micro vessel in the tumor tissue with immunohistochemistry method,and compare the data among the different groups respectively.Results On the twenty-eighth day,the tumor volume of the control group,the monotherapy group and the combination group,averaged 1 700 mm3,19.2 mm3,10.4 mm3,serum VEGF level 88.6 L,35.5,26.3 pg/mL and MVD 43.9,30.3,19.2 respectively,which had significant difference.Conclusion Endostar can strengthen the lethal effect of gemcitabine on the mouse model of human pancreatic cancer.

8

Cite

Cite

Copy

Share

Share

Copy

EFFECTS OF p53 GENE THERAPY COMBINED WITH CYCLOOXYGENASE-2 INHIBITOR ON CYCLOOXYGENASE-2 GENE EXPRESSION AND GROWTH INHIBITION OF HUMAN LUNG CANCER CELLS

Zhao-Xia WANG ; Bin-Bin LU ; Teng WANG ; Yong-Mei YIN ; Wei DE ; Yong-Qian SHU

Journal of Clinical Medicine in Practice.2007;11(5):27-35.

Background Gene therapy by adenovirus-mediated wild-type p53 gene transfer has been shown to inhibit lung cancer growth in vitro, in animal models, and in human clinical trials. The antitumor effect of selective cyclooxygenase (COX)-2 inhibitors has been demonstrated in preclinical studies. However, no information is available on the effects of p53 gene therapy combined with selective COX-2 inhibitor on COX-2 gene expression and growth inhibition of human lung cancer cells. Methods We evaluated the effects of recombinant adenovirus-p53 (Ad-p53) gene therapy combined with selective COX-2 inhibitor on the proliferation, apoptosis, cell cycle arrest of human lung adenocarcinoma A549 cell line, and the effects of tumor suppressor exogenous wild type p53 on COX-2 gene expression. Results Ad-p53 gene therapy combined with selective COX-2 inhibitor celecoxib shows significant synergistic inhibition effects on the growth of human lung adenocarcinoma A549 cell line. Exogenous p53 gene can suppress COX-2 gene expression. Conclusions Significant synergistic inhibition effects of A549 cell line by the combined Ad-p53 and selective COX-2 inhibitor celecoxib may be achieved by enhancement of growth inhibition, apoptosis induction and suppression of COX-2 gene expression. This study provides first evidence that the administration of p53 gene therapy in combination with COX-2 inhibitors might be a new clinical strategy for the treatment or prevention of NSCLC.

9

Cite

Cite

Copy

Share

Share

Copy

A Study on the D-loop Region of Mitochondrial DNA (mtDNA) Mutation in Cervical Carcinomas

Wen-Qun XUE ; Dao-Zhen CHEN

Journal of Clinical Medicine in Practice.2009;13(5):44-47.

Objective Background-study on genesis and development of tumor is mainly concentrated on gene mutation in nucleus. In recent years, however, the role of mitochondrial DNA (mtDNA) mutation in tumor genesis has been given more and more attention, which is the only extra-nucleus DNA in cells of higher animals. Carcinoma of the uterine cervix is a common tumor in gynecology, but there are few reports of mtDNA mutation in this area. The focus of this study was to investigate the mtDNA mutation in tumor tissues of cervical carcinomas and their relationship to tumorigenesis and tumor development. Methods The D-loop region of 24 cervical carcinomas together with the adjacent normal tissues were amplified by PCR and sequenced. Results Among the 24 cervical carcinomas, 30 mutations in 9 patients′ specimen were identified with the mutations rate of 37.5%(9/24). There were 8 microsatellite instabilities among the mutations and 13 new polymorphisms which were not reported previously in the Genbank. Conclusions The D-loop region of mitochondrial DNA is a highly polymorphoric and mutable region and the mutation rate is relatively high in patients with cervical carcinomas.

10

Cite

Cite

Copy

Share

Share

Copy

New developments in colorectal surgery: German experience

KH LINK ; M ROITMAN ; T WEBER

Journal of Clinical Medicine in Practice.2009;13(11):1-6,9. doi:10.3969/j.issn.1672-2353.2009.11.001

Modern therapy in colon and rectal cancer is a multdisciplinary approach, where high quality surgery is still of primary importance. Several new aspects have evolved during the past years, of which screening colonoscopy, standardization of surgical procedures, quality control, the further development of stage dependend multimodal therapies and fast track rehabilitation have significanly contributed to improving patient outcome. Adjuvant chemotherapy in UICC stage Ⅲ colon cancer patients and neoadjuvant radiochemotherapy in T3/4 and/or lymph node positive rectal cancer patients are well established. The preoperative assessment of the circumferential resection margin in rectal cancer is emerging as an important parameter for the indication to neoadjuvant therapy. In a selected group of patients with early T1 colorectal cancer endoscopic polypectomy might be appropriate while laparoscopic surgery for colon cancer is at the edge of becoming an equivalent option to open surgery. Molecular and genetic factors, such as thymidylate synthase, microsatellite instability or mutations of the K-ras protein, might help to better select patients for adjuvant chemotherapy or antibody based antitumor therapy in the future.

Country

China

Publisher

Editorial Department of the Journal of Clinical Medicine in Practice

ElectronicLinks

http://jcmp.yzu.edu.cn

Editor-in-chief

SHI Hongcan

E-mail

sylcyyzz@yzu.edu.cn

Abbreviation

JCMP

Vernacular Journal Title

实用临床医药杂志

ISSN

1672-2353

EISSN

Year Approved

2024

Current Indexing Status

Currently Indexed

Start Year

1997

Description

Journal Introduction "Journal of Practical Clinical Medicine and Pharmacy" was founded in 1997 and is distributed both domestically and internationally. It is recognized as a core journal of science and technology in China, as well as a core journal in Chinese medical and health. The journal targets medical professionals at all levels of healthcare institutions worldwide. The publication adheres strictly to a triple-review system and peer review process for manuscript examination, selecting articles fairly and objectively based on the quality of submissions. Journal Mission: Serving the needs of "Healthy China" and the construction of "New Medical Sciences," the journal adheres to the philosophy of integrating medical and engineering disciplines, staying close to clinical practice, focusing on innovation, and striving for practicality. It aims to promote the integration and development of clinical medicine and engineering. Positioning: Starting from the development needs of the nation and society, the journal actively pursues transformation and upgrading. Through a differentiated positioning strategy, it shifts from a focus solely on "clinical medicine" to "innovative research in the integration of medical and engineering disciplines within clinical medicine." This shift aims to unearth disciplinary development potential and establish a premier academic journal at the intersection of medical-engineering integration and multidisciplinary clinical medicine. Disciplinary Positioning: Integrating medical and engineering disciplines with multidisciplinary innovation and development in clinical medicine. Content Positioning: Primarily focused on applied research with an emphasis on practicality. Journal Development Positioning: Evolving from a platform for paper publication to a knowledge service platform. The close integration and mutual promotion of medicine and engineering have given rise to a convergence point between the two fields, known as biomedical engineering research. Grounded in innovation leadership, our journal aims to construct a platform for multidisciplinary academic exchanges, fostering the integration of medical science with engineering, science, and other disciplines. It publishes the latest achievements reflecting technological and societal advancements in the field of medical engineering. This journal serves as a pivotal forum for clinical medical professionals and biomedical engineering researchers to exchange specialized information and disseminate research findings. Leveraging its unique characteristics and resource strengths, the journal adopts a differentiated positioning strategy to uncover its developmental advantages. It strives to become a premier domestic journal with international impact, specializing in the multidisciplinary integration of medicine and engineering sciences.

Related Sites

WHO WPRO GIM

Help Accessibility
DCMS Web Policy
CJSS Privacy Policy

Powered by IMICAMS( 备案号: 11010502037788, 京ICP备10218182号-8)

Successfully copied to clipboard.